Home
|Insights
|The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

PDF Link

The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

Publication | 09.18.15

Contacts

Barbara H. Ryland
Senior Counsel
- Washington, D.C.
  - D | +1.202.624.2970
YnJ5bGFuZEBjcm93ZWxsLmNvbQ==
Deborah H. Yellin
Partner
She/Her/Hers
- Washington, D.C.
  - D | +1.202.624.2947
ZHllbGxpbkBjcm93ZWxsLmNvbQ==

Insights

Publication | 10.24.24

The Ups And Downs Of SEC's Now-Dissolved ESG Task Force

Publication | 10.17.24
What New EU Packaging Regulation Will Mean For Companies
Publication | 10.16.24
Why Your Institution May Face Enhanced Cybersecurity Requirements
Publication | 10.10.24
Review Shipping Terms In Light Of These 3 Global Challenges

View All Insights

Subscribe

to the latest insights from our team